Close

Auriga Reiterates a 'Buy' on Thermo Fisher Scientific (TMO); Takeaways From Analyst Day

May 24, 2012 1:55 PM EDT
Get Alerts TMO Hot Sheet
Price: $580.66 +0.22%

Rating Summary:
    26 Buy, 6 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 10 | New: 11
Join SI Premium – FREE
Auriga reiterates a 'Buy' on Thermo Fisher Scientific (NYSE: TMO) price target of $65.00.

Analyst, Peter McDonald, said, "Management presented a detailed overview of TMO's diverse businesses, levers for margin improvements, and underlying growth trends in key end markets. While most of the discussion focused on long-term themes, TMO noted current market trends remain relatively steady. In terms of 2013, TMO may face headwinds from NIH sequestration (potential 9% across the board cut). TMO (like other players in the space) is hopeful such a scenario can be avoided, but is incorporating it into its planning. TMO noted even with sequestration, adjusted EPS should grow at least 10% driven by margin expansion, share repurchases and market share gains. Unfortunately, there will likely be no clear resolution until later this year. That said, TMO's breadth and broad product portfolio should help it at least maintain (if not gain) market share."

For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.

Shares of Thermo Fisher Scientific closed at $50.98 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Related Entities

Auriga